Previous 10 | Next 10 |
Axon And Cellebrite Partner to Help Manage and Safeguard Digital Intelligence Data collected and reviewed with Cellebrite Solutions now seamlessly unified in Axon Evidence, allowing investigators to reshape how digital evidence is managed PR Newswire SCOTTSDALE, Ar...
Shares of Axon Enterprise (NASDAQ: AXON) were climbing last month after the company announced a pair of significant new contracts and benefited from an analyst upgrade. According to data from S&P Global Market Intelligence , shares of the law enforcement technology company f...
The Welsh portfolio outperformed the S&P 500 over the first month of 2021. Added a small amount of additional risk to my portfolio to potentially seize the current Wall Street Bets and Robinhood volatility. Bitcoin, Virgin Galactic, and soon First Majestic Silver Company give ...
January was pretty wild, and the rest of the year won't necessarily be tame. But even if the major market indices had closed essentially flat for the first month of 2021, you'd be in great shape for the rest of the year if you had picked the right stocks. Axon Enterprises (NASDAQ:...
Axovant Sciences Ltd ( AXON ) is approaching two key catalysts which may attract the attention of the markets. When I last wrote about the company , I noted that I didn't like the decisions being made at AXON. Throughout 2019 we may begin to see if the company's risky decision, to pivot into ...
Axovant Sciences (NASDAQ: AXON ): Q3 GAAP EPS of -$0.27 misses by $0.01. Cash & equivalents of $84.9M Press Release More news on: Axovant Sciences, Earnings news and commentary, Healthcare stocks news, ,
Expanded pipeline with two investigational gene therapy programs licensed from the University of Massachusetts Medical School for the treatment of GM1 gangliosidosis, Tay-Sachs and Sandhoff diseases First two patients dosed in SUNRISE-PD phase 2 trial of AXO-Lenti-PD for Parkinson's di...
HENDERSON, NV / ACCESSWIRE / January 22, 2019 / The stock market reached a level toward the end of last year where investors and analysts feared a recession. Some of this fear was over a U.S. China trade war; now that we've seen positive news on President Trump talks with President Xi, the m...
Axsome Therapeutics (NASDAQ: AXSM ) +189% on positive AXS-05 data. More news on: Axsome Therapeutics, Luxoft Holding Inc, Loxo Oncology, Stocks on the move, , Read more ...
NEW YORK and BASEL, Switzerland , Jan. 2, 2019 /PRNewswire/ -- Roivant Sciences today announced that Vivek Ramaswamy , Founder and Chief Executive Officer of Roivant, will present an overview of the business as well as new data updates from private companies in the Roivant family ...
News, Short Squeeze, Breakout and More Instantly...
Axon Appoints Isaiah Fields as Chief Legal Officer PR Newswire SCOTTSDALE, Ariz. , July 13, 2022 /PRNewswire/ -- Axon (NASDAQ: AXON), the global leader in connected public safety technologies, today announced the appointment of Isaiah Fields t...
The S&P 500 has fallen 22% from its all-time high, putting the benchmark index in a bear market. Losses of that magnitude can leave even experienced investors feeling rattled, but the worst mistake you can make is allowing yourself to get scared out of high-quality stocks. The durat...
Apple has the kind of brand authority most companies will never achieve, and it has used that competitive advantage to build a very sticky business . Specifically, by pairing first-party hardware with software and services, Apple benefits from recurring revenue and high switching co...